Clinical trial
Statin for Immunomudulation in Sepsis
NCT00452608 · Hospital de Clinicas de Porto Alegre, Other · Unknown status
Key facts
| NCT number | NCT00452608 |
|---|---|
| Title | Statin for Immunomudulation in Sepsis |
| Official title | Use of Statins in Modulation of Inflammatory Answer in Septic Patients |
| Lead sponsor | Hospital de Clinicas de Porto Alegre, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | amido pill, atorvastatina |
| Enrollment | 80 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Mar 27, 2007 |
| Last update posted | Jun 26, 2009 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: